À propos de cet article

Citez

1. Bailey D.B. et al.: No change in the age of diagnosis for fragile X syndrome: findings from a national parent survey. Pediatrics, 124, 527, 2009.10.1542/peds.2008-299219581269Search in Google Scholar

2. Bailey D.B., Raspa M., Olmsted M.G.: Using a parental survey to advance knowledge about the nature and consequences of Fragile X syndrome. A.J.I.D.D., 115, 447, 2010.Search in Google Scholar

3. Chonchaiya W., Schneider A., Hagerman R.J.: Fragile X: a family of disorders. Adv. Pediatr., 56, 165, 2009.Search in Google Scholar

4. Cornish K., Turk J., Levitas A.: Fragile X syndrome and autism: common developmental pathways? Current. Pediatrics. Reviews., 3, 61, 2007.Search in Google Scholar

5. De Rubeis S., Bagni C.: Regulation of molecular pathways in the Fragile X syndrome: insights into Autism Spectrum Disorders. J. Neurodevelop. Disord., 3, 257, 2011.Search in Google Scholar

6. Gabis L.V. et al.: Psychiatric and autistic comorbidity in Fragile X syndrome across ages. J. Child. Neurol., 26, 940, 2011.10.1177/088307381039593721527394Search in Google Scholar

7. Hagerman R.J. (2002). The physical and behavioral phenotype. In: Fragile X syndrome: Diagnosis, Treatment and Research. Hagerman R.J., Cronister A., (editors). Baltimore, MD: Johns Hopkins University Press. p.3.Search in Google Scholar

8. Hagerman R.J.: Lessons from fragile X syndrome regarding neurobiology, autism and neurodegeneration. J. Dev. Behav. Pediatr., 27, 63, 2006.10.1097/00004703-200602000-0001216511373Search in Google Scholar

9. Hersh J.H., Saul R.A., COMMITTEE ON GENETICS.: Clinical report - health supervision for children with fragile X syndrome. Pediatrics, 127, 994, 2011.Search in Google Scholar

10. Hessl D. et al.: A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J. Neurodev. Disord., 1, 33, 2009.10.1007/s11689-008-9001-8276841519865612Search in Google Scholar

11. Hunter J. et al.: Epidemiology of FXS: a systemic review and metaanalysis. Am. J. Med. Genet., 164, 1648, 2014.10.1002/ajmg.a.3651124700618Search in Google Scholar

12. Johnson V.A.T.: Assessment of FMR1 gene mutation at-risk status in young children. Newborn & Infant Nursing Reviews, 8,10,2008.10.1053/j.nainr.2007.12.010Search in Google Scholar

13. McConkie-Rosell A., Finucane B., Cronister A.: Genetic counseling for fragile X syndrome: updated recommendations of the National Society of Genetic Counselors. J. Genet. Counsel., 4, 249, 2005.Search in Google Scholar

14. Turk J.: Fragile X syndrome: lifespan developmental implications for those without as well as with intellectual disability. Curr. Opin. Psychiatry, 24, 387, 2011.10.1097/YCO.0b013e328349bb7721825875Search in Google Scholar

15. Visootsak J. et al.: Fragile X syndrome; an update and review for the primary Pediatrician. Clin. Pediatr. (Phila), 44, 371, 2005.10.1177/00099228050440050115965543Search in Google Scholar

eISSN:
2300-6676
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy